{"DataElement":{"publicId":"2963688","version":"1","preferredName":"Soft Tissue Sarcoma Histologic Grade Type","preferredDefinition":"Text term that represents the risk group associated with soft tissue sarcoma.","longName":"2963683v1.0:2963685v1.00","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"2963683","version":"1","preferredName":"Soft Tissue Sarcoma Histologic Grade","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones._The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","longName":"ST_TE_SA_HC_GE","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2963681","version":"1","preferredName":"Soft Tissue Sarcoma","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","longName":"C9306","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"79667DFC-075B-3EB9-E040-BB89AD43658B","latestVersionIndicator":"Yes","beginDate":"2009-11-27","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-27","modifiedBy":"ONEDATA","dateModified":"2009-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2427327","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05116195-EBA8-7341-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-09","modifiedBy":"ONEDATA","dateModified":"2005-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"79667DFC-0769-3EB9-E040-BB89AD43658B","latestVersionIndicator":"Yes","beginDate":"2009-11-27","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2963685","version":"1","preferredName":"Neoplasm Grade Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A position on a scale of intensity or amount or quality._Type; a subdivision of a particular kind of thing.","longName":"2963685v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High","valueDescription":"High Grade","ValueMeaning":{"publicId":"3288211","version":"1","preferredName":"High Grade","longName":"3288211","preferredDefinition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6DC488-B15F-8FD1-E040-BB89AD432EE0","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B43D00DA-4E41-7AC2-E040-BB89AD434B8C","beginDate":"2009-11-27","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-12-16","modifiedBy":"ONEDATA","dateModified":"2011-12-16","deletedIndicator":"No"},{"value":"Intermediate","valueDescription":"Intermediate Grade","ValueMeaning":{"publicId":"3335158","version":"1","preferredName":"Intermediate Grade","longName":"3335158","preferredDefinition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intermediate Grade","conceptCode":"C28083","definition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B43D00DA-4E4B-7AC2-E040-BB89AD434B8C","latestVersionIndicator":"Yes","beginDate":"2011-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B43D00DA-4E64-7AC2-E040-BB89AD434B8C","beginDate":"2009-11-27","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-12-16","modifiedBy":"ONEDATA","dateModified":"2011-12-16","deletedIndicator":"No"},{"value":"Low","valueDescription":"Low Grade","ValueMeaning":{"publicId":"3288210","version":"1","preferredName":"Low Grade","longName":"3288210","preferredDefinition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6DC488-B13C-8FD1-E040-BB89AD432EE0","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B43D00DA-4E78-7AC2-E040-BB89AD434B8C","beginDate":"2009-11-27","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-12-16","modifiedBy":"ONEDATA","dateModified":"2011-12-16","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B26CFDCE-5837-EE3A-E040-BB89AD433D11","beginDate":"2009-11-27","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-23","modifiedBy":"ONEDATA","dateModified":"2011-11-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3335157","version":"1","preferredName":"Neoplasm Grade Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:A position on a scale of intensity or amount or quality.:Type; a subdivision of a particular kind of thing.","longName":"C3262:C48309:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B43D00DA-4DF0-7AC2-E040-BB89AD434B8C","latestVersionIndicator":"Yes","beginDate":"2011-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-12-16","modifiedBy":"ONEDATA","dateModified":"2011-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"79667DFC-0790-3EB9-E040-BB89AD43658B","latestVersionIndicator":"Yes","beginDate":"2009-11-27","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-27","modifiedBy":"COOPERM","dateModified":"2017-10-17","changeDescription":"11/23/11mn-added cs for 2024 & disease status, added contact & origin info. capped PVs. 12/16/11: changed PV meaning to use the fit concepts and changed rep term Soft tissue sarcoma type to Neoplasm Grade Type per RA.wz Retired due to not in use and as part of the caDSR cleanup. AK 6/30/17\r\nChanged context to OCG, Origin to HCMI, released, and added to Rhabdomyosarcoma form. 10/17/17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964892","version":"1","longName":"2024r1: Sarcoma Pre-HSCT Data","context":"NHLBI"},{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"5806871","version":"1","longName":"Rhabdomyosarcoma","context":"OCG"}]}],"AlternateNames":[{"name":"sar_base_diag_sft_tmr_grd","type":"NMDP_FN","context":"NHLBI"},{"name":"soft_tissue_sarcoma_histologic_grade","type":"HCMI Name","context":"OCG"}],"ReferenceDocuments":[{"name":"What was the soft-tissue sarc","type":"Preferred Question Text","description":"What was the soft-tissue sarcoma grade?","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7966FC1B-51FD-A951-E040-BB89AD43248A","latestVersionIndicator":"Yes","beginDate":"2009-11-27","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-27","modifiedBy":"COOPERM","dateModified":"2017-10-17","changeDescription":"11/23/11mn-updated after changes to VD. added cs for disease status & added contact info. 12/16/11: updated to reflect the change of VD.wz Retired due to not in use and as part of the caDSR cleanup. AK 6/30/17. 09/22/2017 wz changed status to Released to be used by HCMI task. 10/17/17 Changed context to OCG and source to HCMI with permission of NMDP, AK. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}